Cargando…

Rituximab for interstitial pneumonia with autoimmune features at two medical centres

OBJECTIVES: Many patients with interstitial lung disease (ILD) have autoimmune manifestations but do not meet criteria for a systemic rheumatic disease. A subset meets criteria for interstitial pneumonia with autoimmune features (IPAF) and have ILD requiring therapy. We conducted a multicentre obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Silva, Kristin M, Ventura, Iazsmin Bauer, Bolster, Marcy B, Castelino, Flavia V, Sharma, Amita, Little, Brent P, Adegunsoye, Ayodeji, Strek, Mary E, Choi, Hyon, Montesi, Sydney B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570147/ https://www.ncbi.nlm.nih.gov/pubmed/34755024 http://dx.doi.org/10.1093/rap/rkab051

Ejemplares similares

Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease
por: Strykowski, Rachel K, et al.
Publicado: (2022)

Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard
por: Lee, Cathryn T., et al.
Publicado: (2022)

Association of Black Race with Outcomes in COVID-19 Disease: A Retrospective Cohort Study
por: Adegunsoye, Ayodeji, et al.
Publicado: (2020)

High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease
por: Tyker, Albina, et al.
Publicado: (2021)

Therapeutic Approach to Adult Fibrotic Lung Diseases
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease
por: Biblowitz, Kathleen, et al.
Publicado: (2021)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Practice guidelines for interstitial lung diseases: Widening the reach
por: Montesi, Sydney B.
Publicado: (2020)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
por: Sclafani, A., et al.
Publicado: (2019)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Automated CT Analysis of Major Forms of Interstitial Lung Disease
por: Crews, Marlee S., et al.
Publicado: (2020)

Diagnostic test interpretation and referral delay in patients with interstitial lung disease
por: Pritchard, David, et al.
Publicado: (2019)

Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation
por: Macklin, Michael, et al.
Publicado: (2023)

N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia
por: Oldham, Justin M., et al.
Publicado: (2018)

Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
por: Kapuczinski, Abeline, et al.
Publicado: (2021)

Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases
por: Castelino, Flavia V., et al.
Publicado: (2021)

Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
por: Castelino, Flavia V, et al.
Publicado: (2010)

Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
por: Chung, Jonathan H., et al.
Publicado: (2021)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Treating lung cancer in patients with interstitial lung disease: what do we know?
por: Graur, Alexander, et al.
Publicado: (2023)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
por: Maleki, Arash, et al.
Publicado: (2022)

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

Rituximab-induced interstitial lung disease: five case reports
por: Naqibullah, Matiuallah, et al.
Publicado: (2015)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Profile of romosozumab and its potential in the management of osteoporosis
por: Lim, Sian Yik, et al.
Publicado: (2017)

Addressing the rheumatology workforce shortage: A multifaceted approach
por: Miloslavsky, Eli M., et al.
Publicado: (2020)

Clinical Utility of Romosozumab in the Management of Osteoporosis: Focus on Patient Selection and Perspectives
por: Lim, Sian Yik, et al.
Publicado: (2022)

Hospitalizations in patients with idiopathic pulmonary fibrosis
por: Kim, Hyun J., et al.
Publicado: (2021)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
por: Adegunsoye, Ayodeji, et al.
Publicado: (2015)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy
por: Dumitrascu, Oana M., et al.
Publicado: (2017)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Applying Educational Theory to Optimize Trainee Education in the Ambulatory Virtual Care Environment
por: Zickuhr, Lisa, et al.
Publicado: (2021)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
por: Lee, Yuna, et al.
Publicado: (2006)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a4drnb61hm5o9behdansoaokbg